Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AstraZeneca PLC | Stockholm | Healthcare | Pharmaceuticals | SEK 2.18T | 31.1x | 1.8 | SEK 1,403 | -3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.8% Upside | Upgrade to Pro+ | |
Swedish Orphan Biovitrum | Stockholm | Healthcare | Pharmaceuticals | SEK 94.31B | 24.1x | 0.5 | SEK 275 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 35.3% Upside | Upgrade to Pro+ | |
Getinge B | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 58.79B | 35.9x | -1.15 | SEK 194.50 | -5.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.2% Upside | Upgrade to Pro+ | |
Sectra | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 46.99B | 79.8x | 2.08 | SEK 243.90 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.5% Downside | Upgrade to Pro+ | |
Camurus AB | Stockholm | Healthcare | Pharmaceuticals | SEK 31.84B | 73.6x | -19.93 | SEK 543.50 | -3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 33.4% Upside | Upgrade to Pro+ | |
Medicover | Stockholm | Healthcare | Healthcare Providers & Services | SEK 29.49B | 161.6x | -29.33 | SEK 196.40 | -4.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.8% Upside | Upgrade to Pro+ | |
Vimian Group AB | Stockholm | Healthcare | Pharmaceuticals | SEK 21.48B | 100.6x | 1.3 | SEK 40.45 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.7% Upside | Upgrade to Pro+ | |
Vitrolife | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 21.09B | 41.1x | 0.39 | SEK 155.70 | -4.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bonesupport | Stockholm | Healthcare | Pharmaceuticals | SEK 20.38B | 151.4x | -3.19 | SEK 309.40 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 42.2% Upside | Upgrade to Pro+ | |
Elekta B | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 19.31B | 18.6x | -0.72 | SEK 48.26 | -3.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.7% Upside | Upgrade to Pro+ | |
AddLife | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 17.77B | 71.3x | 2.22 | SEK 146.60 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.8% Upside | Upgrade to Pro+ | |
BioArctic | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 14.99B | -84.8x | 0.54 | SEK 169.60 | -3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BioGaia B | Stockholm | Healthcare | Pharmaceuticals | SEK 10.27B | 29.4x | -7.96 | SEK 101.50 | -6.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Arjo | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 9.34B | 18.8x | 5.41 | SEK 34.56 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.5% Upside | Upgrade to Pro+ | |
Ambea | Stockholm | Healthcare | Healthcare Providers & Services | SEK 8.72B | 14.4x | 0.36 | SEK 103.30 | -3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.3% Upside | Upgrade to Pro+ | |
Attendo International publ AB | Stockholm | Healthcare | Healthcare Providers & Services | SEK 8.68B | 20.3x | 0.91 | SEK 57.80 | -3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12% Upside | Upgrade to Pro+ | |
Xvivo Perfusion AB | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 8.28B | 48.1x | 0.71 | SEK 263 | -5.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Implantica AG | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 7.93B | -42.3x | -21.28 | SEK 27 | -3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
RaySearch Labs B | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 7.23B | 35.5x | 0.26 | SEK 211 | -5.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biotage AB | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 7.16B | 25.3x | 4.18 | SEK 89.20 | -5.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Surgical Science Sweden | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 5.95B | 45.2x | -1.12 | SEK 116.20 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Swedencare | Stockholm | Healthcare | Pharmaceuticals | SEK 5.83B | 59.2x | 0.92 | SEK 36.52 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CellaVision AB | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 3.86B | 27.4x | 3.57 | SEK 161.60 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 42.9% Upside | Upgrade to Pro+ | |
Flerie AB | Stockholm | Healthcare | Pharmaceuticals | SEK 3.24B | -12.8x | -0.21 | SEK 41.74 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 35.7% Upside | Upgrade to Pro+ | |
Medistim ASA | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 2.84B | 28.8x | SEK 170.14 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Humana | Stockholm | Healthcare | Healthcare Providers & Services | SEK 2.17B | 14.6x | -0.7 | SEK 41.80 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.7% Upside | Upgrade to Pro+ | |
BICO Group | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 2.02B | -22.3x | -0.25 | SEK 28.54 | -4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Stille AB | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 1.90B | 32.9x | 1.61 | SEK 211 | -4.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.8% Upside | Upgrade to Pro+ | |
BioInvent International | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.75B | -4.1x | 0.15 | SEK 26.50 | -5.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cereno Scientific | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.65B | -16.6x | 0.23 | SEK 5.87 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SyntheticMR | Spotlight | Healthcare | Healthcare Equipment & Supplies | SEK 1.65B | -10.4x | 0.06 | SEK 4.02 | -4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vicore Pharma Holding AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.61B | -5.5x | -0.16 | SEK 6.80 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Devyser Diagnostics AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.59B | -26.4x | 2.11 | SEK 94.60 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Carasent AB | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 1.58B | -38.6x | -11.53 | SEK 21.32 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.4% Upside | Upgrade to Pro+ | |
Hansa Biopharma | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.48B | -1.7x | -0.1 | SEK 21.82 | -3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Egetis Therapeutics AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.44B | -3.6x | -0.28 | SEK 4.02 | -6.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Intellego Technologies AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.36B | 13.7x | 1.15 | SEK 50.60 | 9.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Paxman | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 1.29B | 31.6x | 0.09 | SEK 67.60 | -4.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 38.8% Upside | Upgrade to Pro+ | |
Genovis AB | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 1.20B | 37x | -0.8 | SEK 18.48 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
OssDsign | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 1.16B | -24.3x | -0.34 | SEK 11.40 | -4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.4% Upside | Upgrade to Pro+ | |
Nanoform Finland Plc | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.09B | -3.7x | 0.69 | SEK 11.74 | -8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
XSpray Pharma | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 969.31M | -3.1x | 0.14 | SEK 26.10 | -9.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
C-Rad | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 930.12M | 16.6x | 0.29 | SEK 27.60 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bactiguard Holding AB | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 921.65M | -30.9x | -0.44 | SEK 26.70 | -6.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Diamyd Medical | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 883.71M | -5.3x | 0.55 | SEK 8.49 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SynAct Pharma AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 879.22M | -8.1x | -0.14 | SEK 16.96 | -5.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -5.9% Downside | Upgrade to Pro+ | |
ADDvise Group AB A | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 876.86M | 2.6x | -0.17 | SEK 4.41 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Enzymatica publ AB | Stockholm | Healthcare | Pharmaceuticals | SEK 868.99M | -12.8x | -2.12 | SEK 3.56 | -11% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -30.6% Downside | Upgrade to Pro+ | |
Sedana Medical | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 753.97M | -69x | -1 | SEK 7.60 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nykode Therapeutics | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 733.07M | -1.9x | SEK 13.98 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |